-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Inhibikase Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate for Q2 2024.
- Inhibikase Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending June 30, 2024 was $115K.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)